Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Current therapeutic options for multiple sclerosis

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Current therapeutic options for multiple sclerosis. Inpharma Wkly. 692, 17–18 (1989). https://doi.org/10.1007/BF03285860

    Download citation

    Keywords

    • Multiple Sclerosis
    • Multiple Sclerosis Patient
    • Interferon Alpha
    • Aminopyridine
    • Interferon Beta